Edition:
United Kingdom

IQVIA Holdings Inc (IQV.N)

IQV.N on New York Stock Exchange

117.98USD
7 Dec 2018
Change (% chg)

$-3.87 (-3.18%)
Prev Close
$121.85
Open
$121.04
Day's High
$121.81
Day's Low
$117.10
Volume
453,383
Avg. Vol
313,300
52-wk High
$135.43
52-wk Low
$91.70

Latest Key Developments (Source: Significant Developments)

IQVIA Announces Launch Of Secondary Public Offering & Repurchase Of Common Stock
Thursday, 29 Nov 2018 

Nov 29 (Reuters) - IQVIA Holdings Inc ::IQVIA ANNOUNCES LAUNCH OF SECONDARY PUBLIC OFFERING AND REPURCHASE OF COMMON STOCK.IQVIA HOLDINGS - LAUNCH OF SECONDARY PUBLIC OFFERING OF 6 MILLION SHARES BY CERTAIN OF ITS EXISTING STOCKHOLDERS.IQVIA HOLDINGS INC - EXPECTS TO FUND REPURCHASE WITH CASH ON HAND AND BORROWINGS FROM ITS REVOLVING CREDIT FACILITY.IQVIA HOLDINGS - INTENDS TO REPURCHASE FROM UNDERWRITER 2 MILLION SHARES.IQVIA HOLDINGS - EXPECTS TO FUND REPURCHASE WITH CASH ON HAND, BORROWINGS FROM REVOLVING CREDIT FACILITY.  Full Article

IQVIA Q3 GAAP Earnings Per Share $0.29
Monday, 22 Oct 2018 

Oct 22 (Reuters) - IQVIA Holdings Inc ::IQVIA REPORTS THIRD-QUARTER 2018 RESULTS AND UPDATES FULL-YEAR 2018 GUIDANCE.Q3 ADJUSTED EARNINGS PER SHARE $1.42.Q3 GAAP EARNINGS PER SHARE $0.29.Q3 REVENUE $2.594 BILLION VERSUS I/B/E/S VIEW $2.58 BILLION.Q3 EARNINGS PER SHARE VIEW $1.39 -- THOMSON REUTERS I/B/E/S.REAFFIRMING MID-POINT OF FULL-YEAR 2018 REVENUE GUIDANCE INCLUSIVE OF FOREIGN CURRENCY HEADWIND.RAISING MID-POINT OF FULL-YEAR 2018 ADJUSTED EBITDA AND ADJUSTED DILUTED EPS GUIDANCE.SEES FY 2018 ADJUSTED DILUTED EPS $5.45 - $5.55.R&DS CONTRACTED BACKLOG INCLUDING REIMBURSED EXPENSES WAS $16.4 BILLION AT SEPTEMBER 30, 2018.COMPANY EXPECTS APPROXIMATELY $4.6 BILLION OF R&DS CONTRACTED BACKLOG AT SEPT. 30 TO CONVERT TO REVENUE IN NEXT TWELVE MONTHS.FY2018 EARNINGS PER SHARE VIEW $5.50 -- THOMSON REUTERS I/B/E/S.  Full Article

IQVIA Reports Q2 Adjusted Earnings Per Share $1.29
Tuesday, 24 Jul 2018 

July 24 (Reuters) - IQVIA Holdings Inc ::IQVIA REPORTS SECOND-QUARTER 2018 RESULTS AND RAISES FULL-YEAR 2018 REVENUE AND PROFIT GUIDANCE.Q2 ADJUSTED EARNINGS PER SHARE $1.29.Q2 GAAP EARNINGS PER SHARE $0.29.Q2 REVENUE $2.567 BILLION VERSUS I/B/E/S VIEW $2.5 BILLION.SEES Q3 2018 ADJUSTED EARNINGS PER SHARE $1.35 TO $1.42.SEES Q3 2018 REVENUE $2.55 BILLION TO $2.6 BILLION.Q2 EARNINGS PER SHARE VIEW $1.23 -- THOMSON REUTERS I/B/E/S.Q3 EARNINGS PER SHARE VIEW $1.34, REVENUE VIEW $2.53 BILLION -- THOMSON REUTERS I/B/E/S.  Full Article

IQVIA Announces Senior Secured Credit Facility Transaction to Refinance Existing Indebtedness
Monday, 11 Jun 2018 

June 11 (Reuters) - IQVIA Holdings Inc ::IQVIA ANNOUNCES SENIOR SECURED CREDIT FACILITY TRANSACTION TO REFINANCE EXISTING INDEBTEDNESS.IQVIA HOLDINGS INC - PLACED APPROXIMATELY $1.65 BILLION OF USD AND EUR TERM B LOANS.IQVIA HOLDINGS - PROCEEDS OF ADDITIONAL TERM B LOANS USED TO PAY DOWN REVOLVING CREDIT FACILITY, REFINANCE $650 MILLION OF EXISTING USD TERM B LOANS DUE 2024.  Full Article

IQVIA Reaffirms Its Second-Quarter and FY 2018 Guidance
Friday, 18 May 2018 

May 17 (Reuters) - IQVIA Holdings Inc ::SEES FY 2018 REVENUE GUIDANCE RANGE OF $10.05 BILLION TO $10.25 BILLION.IQVIA REAFFIRMS ITS SECOND-QUARTER AND FULL-YEAR 2018 GUIDANCE, INCLUDING ADJUSTED EPS GROWTH OF 13.6% TO 20.4% AND 14.3% TO 19.9%, RESPECTIVELY.REAFFIRMS FY 2018 ADJUSTED EARNINGS PER SHARE VIEW $5.20 TO $5.45.  Full Article

IQVIA Responds To FDA Statement Regarding Conversion Measurement Issue
Wednesday, 16 May 2018 

May 16 (Reuters) - IQVIA Holdings Inc ::IQVIA RESPONSE TO FDA STATEMENT.IQVIA HOLDINGS - RECENTLY MADE CORRECTION TO KILOGRAM CONVERSION MEASUREMENT IN UNITED STATES IQVIA NATIONAL SALES PERSPECTIVE MARKET RESEARCH SERVICE.IQVIA HOLDINGS INC - CORRECTION AFFECTS REPORTED MEASUREMENTS FOR TRANSDERMAL PATCHES IN OPIOID MARKET.IQVIA HOLDINGS INC - IQVIA'S INTERNAL PROCESSES HAD ALREADY IDENTIFIED MEASUREMENT CONVERSION ISSUE PRIOR TO FDA'S NOTIFICATION.IQVIA HOLDINGS INC - NOTIFIED CO'S CLIENTS ABOUT THE MEASUREMENT CONVERSION ISSUE IN APRIL OF THIS YEAR.IQVIA - MEASUREMENT CONVERSION ISSUE DOES NOT IMPACT WIDELY USED U.S. & GLOBAL DOLLAR & UNIT INFORMATION IN NATIONAL SALES PERSPECTIVE.IQVIA HOLDINGS INC - ONGOING STEPS HAVE BEEN UNDERTAKEN TO CORRECT THE MEASUREMENT CONVERSION ISSUE IN THIS OFFERING.IQVIA HOLDINGS INC - WILL CONTINUE WORKING WITH FDA TO RESOLVE THE CONCERNS.IQVIA - MEASUREMENT CONVERSION ISSUE DOES NOT IMPACT INFORMATION IN ANY OTHER IQVIA MARKET RESEARCH SERVICES, METHODOLOGIES OR OFFERINGS.  Full Article

Iqvia Announces Launch Of Secondary Public Offering And Repurchase Of Common Stock
Tuesday, 15 May 2018 

May 15 (Reuters) - IQVIA Holdings Inc ::IQVIA ANNOUNCES LAUNCH OF SECONDARY PUBLIC OFFERING AND REPURCHASE OF COMMON STOCK.IQVIA HOLDINGS - LAUNCH UNDERWRITTEN, SECONDARY PUBLIC OFFERING OF 10 MILLION SHARES OF ITS COMMON STOCK BY CERTAIN OF ITS EXISTING STOCKHOLDERS.  Full Article

IQVIA Announces Pricing Of Secondary Public Offering
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - IQVIA Holdings Inc ::IQVIA ANNOUNCES PRICING OF SECONDARY PUBLIC OFFERING.IQVIA HOLDINGS INC - ‍PRICING OF UNDERWRITTEN, SECONDARY PUBLIC OFFERING OF 10 MILLION SHARES OF ITS COMMON STOCK BY CERTAIN OF ITS EXISTING STOCKHOLDERS​.IQVIA HOLDINGS INC - ‍IQVIA INTENDS TO REPURCHASE FROM UNDERWRITER 2.5 MILLION SHARES​.IQVIA HOLDINGS-REPURCHASE WILL BE COMPLETED OUTSIDE CO'S EXISTING SHARE REPURCHASE PROGRAM, UNDER WHICH CO HAS ABOUT $195 MILLION OF REMAINING AVAILABILITY​.  Full Article

IQVIA Announces Launch Of Secondary Public Offering And Repurchase Of Common Stock
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Iqvia Holdings Inc ::IQVIA ANNOUNCES LAUNCH OF SECONDARY PUBLIC OFFERING AND REPURCHASE OF COMMON STOCK.IQVIA HOLDINGS INC - ‍LAUNCH OF AN UNDERWRITTEN, SECONDARY PUBLIC OFFERING OF 10 MILLION SHARES OF ITS COMMON STOCK​.  Full Article

QuintilesIMS Holdings will be changing its name to IQVIA
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Quintiles Ims Holdings Inc ::Will be changing its name to IQVIA effective November 6, 2017​.Beginning Nov 15, equity shares of co will trade on NYSE under new name and new ticker symbol "IQV."​.  Full Article

UPDATE 6-Amazon to buy PillPack in potentially disruptive drug retail push

June 28 Amazon.com Inc said on Thursday it would buy small online pharmacy PillPack, a move that will put the world's biggest online retailer in direct competition with drugstore chains, drug distributors and pharmacy benefit managers.